Dan Darnley is currently the Vice President of Intellectual Property at Syndax Pharmaceuticals. They have held various senior legal positions in the pharmaceutical industry, including Vice President and Chief Intellectual Property Counsel at Radius Health, Inc., and Vice President at Black Diamond Therapeutics, where they also served as a consultant. Previously, Darnley was VP, General Counsel, and Commercial Compliance Officer at BioDelivery Sciences International. They began their legal career after earning a JD from Indiana University Bloomington and continue their education at the University of Notre Dame.
This person is not in any teams
This person is not in any offices